Overview
Precipio Diagnostics provides hematology-focused cancer diagnostics services, combining expert pathology review with advanced molecular testing to reduce misdiagnosis rates for patients with blood cancers.
More in Clinical Diagnostics
Latest industry news
Tempus AI Wins FDA Approval for Tumor-Only Genomic Test, Expanding Oncology Access
2026-09-17 · Product
AGBT Names 2026 Precision Health Next Gen Leadership Award Recipients
2026-09-16 · Industry
Gene Solutions Eyes Hong Kong IPO to Finance Next Phase of Genomics Expansion
2026-09-15 · Funding
Vietnam Moves to Address Regulatory and Ethical Gaps in DNA Testing Deployment
2026-09-14 · Policy
Company details
Category
🏥 Clinical Diagnostics
Location
New Haven, CT, USA
Funding
Publicly traded — NASDAQ: PRPO
Website
precipiodx.comListed
2026-08-03
Is this your company?
Claim this listing to add your logo, full description, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach genomics professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →